MAGNetic QRS-Fragmentation in Patients With Myocardial InfarcTion and Moderately RedUceD Ejection Fraction (MAGNITUDE)

This study has been terminated.
(BMDSys GmbH, manufacturer of the MFI QRS Fragmentation Systems to be used in the MAGNITUDE study, has filed for insolvency.)
Sponsor:
Collaborators:
Medtronic
Medtronic Clinical Research Institute
Information provided by (Responsible Party):
Medtronic Bakken Research Center
ClinicalTrials.gov Identifier:
NCT01972126
First received: October 24, 2013
Last updated: April 2, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: November 2017
  Estimated Primary Completion Date: November 2017 (Final data collection date for primary outcome measure)